これまでの実績

2011年 (total impact fac. 113.223 ave. 5.392)

Phung, T. T. B., Sugamata, R., Uno, K., Aratani, Y., Ozato, K., Kawachi, S., Nguyen, L. T., Nakayama, T., and Suzuki, K.: Key role of regulated upon activation normal T-cell expressed and secreted, nonstructural protein1 and myeloperoxidase in cytokine storm induced by influenza virus PR-8 (A/H1N1) infection in A549 bronchial epithelial cells. Microbiol. Immunol. 55:874-884 (2011). (1.227)

Kidoya, H., Kunii, N., Naito, H., Muramatsu, T., Okamoto, Y., Nakayama, T., and Takakura, N.: The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy. Oncogene 31:3254-3264 (2011). (7.414)

Endo, Y., Iwamura, C., Kuwahara, M., Suzuki, A., Sugaya, K., Tumes, D. J., Tokoyoda, K., Hosokawa, H., Yamashita, M., and Nakayama, T.: Eomesodermin controls interleukin-5 production in memory T helper 2 cells through inhibition of activity of the transcription factor GATA3. Immunity 35:733-745 (2011). (24.221)

Tsuyusaki, J., Kuroda, F., Kasuya, Y., Ishizaki, S., Yamauchi, K., Sugimoto, H., Kono, T., Iwamura, C., Nakayama, T., and Tatsumi, K.: Cigarette smoke-induced pulmonary inflammation is attenuated in CD69-deficient mice. J. Recept. Sig. Transduct. Res. 31:434-439 (2011). (1.822)

Takahashi, K., Hirose, K., Kawashima, S., Niwa, Y., Wakashin, H., Iwata, A., Tokoyoda, K., Renauld, J.-C., Iwamoto, I., Nakayama, T., and Nakajima, H.: IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J. Allergy Clin. Immunol. 128:1067-1076 (2011). (9.273)

Yamauchi, K., Kasuya, Y., Kuroda, F., Tanaka, K., Tsuyusaki, J., Ishizaki, S., Matsunaga, H., Iwamura, C., Nakayama, T., and Tatsumi, K.: Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin. Respir. Res. 12:131 (2011). (2.859)

Exley, M. A., and Nakayama, T.: NKT-cell-based immunotherapies in clinical trials. Clin. Immunol. 140:117-118 (2011). (3.932)

Motohashi, S., Okamoto, Y., Yoshino, I., and Nakayama, T.: Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer. Clin. Immunol. 140:167-176 (2011). (3.932)

Nagao, T., Suzuki, K., Utsunomiya, K., Matsumura, M., Saiga, K., Wang, P.-C., Minamitani, H., Aratani, Y., Nakayama, T., and Suzuki, K.: Direct activation of glomerular endothelial cells by anti-moesin activity of anti-myeloperoxidase antibody. Nephrol. Dial. Transplant. 26:2752-2760 (2011). (3.564)

Kitajima, M., Ito, T., Tumes, D. J., Endo, Y., Onodera, A., Hashimoto, K., Motohashi, S., Yamashita, M., Nishimura, T., Ziegler, F. S., and Nakayama, T.: Memory type 2 helper T cells induce long-lasting anti-tumor immunity by activating natural killer cells. Cancer Res. 71:4790-4798 (2011). (8.234)

Fujii, H., Ato, M., Takahashi, Y., Otake, K., Hashimoto, S., Kaji, T., Tsunetsugu-Yokota, Y., Fujita, M., Adachi, A., Nakayama, T., Taniguchi, M., Koyasu, S., and Takemori, T.: HIV-1 Nef impairs multiple T-cell functions in antigen-specific immune response in mice. Int. Immunol. 23:433-441 (2011). (3.301)

Asada, S., Kuroda, M., Aoyagi, Y., Fukaya, Y., Tanaka, S., Konno, S., Tanio, M., Aso, M., Satoh, K., Okamoto, Y., Nakayama, T., Saito, Y., and Bujo, H.: Ceiling culture-derived proliferative adipocytes retain high adipogenic potential suitable for use as a vehicle for gene transduction therapy. Am. J. Physiol. Cell Physiol. 301: C181-185 (2011). (3.817)

Kitajima, M., Lee, H.-C., Nakayama, T., and Ziegler, S. F.: TSLP enhances the function of helper type2 cells. Eur. J. Immunol. 41:1862-1871 (2011). (4.942)

Horiuchi, S., Onodera, A., Hosokawa, H., Watanabe, Y., Tanaka, T., Sugano, S., Suzuki, Y., and Nakayama, T.: Genome-wide analysis reveals unique regulation of transcription of Th2-specific genes by GATA3. J. Immunol. 186:6378-6389 (2011). (5.745)

Hirasaki, Y., Iwamura, C., Yamashita, M., Ito, T., Kitajima, M., Shinoda, K., Namiki, T., Terasawa, K., and Nakayama, T.: Repressor of GATA negatively regulates murine contact hypersensitivity through the inhibition of type-2 allergic responses. Clin. Immunol. 139:267-276 (2011). (3.932)

Fujimura, T., Yonekura, S., Horiguchi, S., Taniguchi, Y., Saito, A., Yasueda, H., Inamine, A., Nakayama, T., Takemori, T., Taniguchi, M., Sakaguchi, M., and Okamoto, Y.: Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in two-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis. Clin. Immunol. 139:65-74 (2011). (3.932)

Yamashita, J., Iwamura, C., Sasaki, T., Mitsumori, K., Ohshima, K., Hada, K., Hara, N., Takahashi, M., Kaneshiro, Y., Tanaka, H., Kaneko, K., and Nakayama, T.: ApolipoproteinA-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function. J. Immunol. 186:3410-3420 (2011). (5.745)

Yamasaki, K., Horiguchi, S., Kurosaki, M., Kunii, N., Nagato, K., Hanaoka, H., Shimizu, N., Ueno, N., Yamamoto, S., Taniguchi, M., Motohashi, S., Nakayama, T., and Okamoto, Y.: Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy. Clin. Immunol. 138:255-265 (2011). (3.932)

Aoyagi, T., Yamamoto, N., Hatta, M., Tanno, D., Miyazato, A., Ishii, K., Suzuki, K., Nakayama, T., Taniguchi, M., Kunishima, H., Hirakata, Y., Kaku, M., and Kawakami, K.: Activation of pulmonary invariant NKT cells leads to exacerbation of acute lung injury caused by LPS through local production of IFN-γ and TNF-α by Gr-1+ monocytes. Int. Immunol. 23:97-108 (2011). (3.301)

Phung, T. T. B., Luong, S. T., Kawachi, S., Nunoi, H., Nguyen, L. T., Nakayama, T., and Suzuki, K.: Interleukin 12 and myeloperoxidase (MPO) in Vietnamese children with acute respiratory distress syndrome due to Avian influenza (H5N1) infection. J. Infect. 62:104-106 (2011). (3.805)

Kurosaki, M., Horiguchi, S., Yamasaki, K., Uchida, Y., Motohashi, S., Nakayama, T., Sugimoto, A., and Okamoto, Y.: Migration and immunological reaction after the administration of αGalCer-pulsed antigen-presenting cells into the submucosa of patients with head and neck cancer. Cancer Immunol. Immunother. 60:207-215 (2011). (4.293)